Researchers developed a new gene-editing platform called transcription activator-like effector-linked deaminases, or TALED for short.

A three-year-old consortium has finally filled in that remaining DNA, providing the first complete, gapless genome sequence.

Cancer detection is a major public health challenge, and the methods currently available to achieve it are often expensive and invasive.

The diseases covered by the test belong to a class of over 50 diseases caused by unusually-long repetitive DNA sequences in a person’s genes